December 3, 2024 - 03:14

A recent lawsuit has shed light on significant campaign finance violations committed by Facebook's parent company, Meta. The company was found to have sold advertisements over 800 times without the necessary public disclosures. This lack of transparency raised concerns about the integrity of political advertising in the state of Washington.
On Tuesday, a Washington court upheld a record penalty of $24.6 million against Meta, marking a significant moment in the enforcement of campaign finance laws. The ruling emphasizes the importance of accountability in political advertising, ensuring that companies adhere to regulations designed to promote transparency and fairness in the electoral process.
Critics have long argued that social media platforms must take greater responsibility for the content they promote and the way they handle political ads. This ruling serves as a reminder that violations of campaign finance laws will not be tolerated and that companies must comply with established guidelines to maintain the integrity of democratic processes.
November 11, 2026 - 03:35
Resideo Reports Third Quarter 2026 Financial Performance and Outlook UpdateResideo Technologies, Inc. has shared its financial results for the third quarter of 2026, which concluded on October 3. The company, known for its innovative control and sensing solutions in the...
November 10, 2026 - 13:34
Hong Kong's Financial Transformation: China Aims for Global InfluenceA recent report explores how Beijing is reshaping Hong Kong into a key player in the global financial landscape. The analysis, conducted by ASPI`s Center for China Analysis and Enodo Economics,...
November 10, 2026 - 09:52
BitGo Holdings Reports Significant Revenue Decline in Q3BitGo Holdings, known by the ticker BTGO, has revealed a troubling 50.9% drop in year-over-year revenue for the third quarter. The decline is largely attributed to a slowdown in digital asset...
November 9, 2026 - 21:06
New Drug Application Submitted for Azetukalner in Focal SeizuresIn September 2026, a New Drug Application for azetukalner, a treatment for focal seizures, was submitted to the U.S. Food and Drug Administration. This marks a significant step forward in expanding...